PT  - JOURNAL ARTICLE
AU  - Jessica Ong
AU  - Nishant Hemanth Davidoss
AU  - Anant Bhosale
AU  - Chandrakumar Balaratnasingam
TI  - Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex)
AID  - 10.1136/bcr-2020-235102
DP  - 2020 Nov 01
TA  - BMJ Case Reports
PG  - e235102
VI  - 13
IP  - 11
4099  - http://casereports.bmj.com/content/13/11/e235102.short
4100  - http://casereports.bmj.com/content/13/11/e235102.full
SO  - BMJ Case Reports2020 Nov 01; 13
AB  - A 59-year-old man with diabetic macular oedema was treated with a dexamethasone intravitreal implant (Ozurdex) to his right eye. Immediately after injection, the implant was noted to have extruded into the perilimbal subconjunctival space. The remnants of the implant were expeditiously removed the following day to avoid corneal decompensation and permanent corneal oedema. Endothelial decompensation secondary to the migration of dexamethasone implants into the subconjunctival space or anterior chamber is a recognised complication of Ozurdex injection. The patient recovered well postoperatively with no further complications. He was planned for a new Ozurdex implant 1 month later.